Please sign in to follow a disease.
Chronic liver failure
MONDO:0100193Liver failure that develops slowly and gradually for some time, possibly for years, often as the result of cirrhosis, or malnutrition.
Also known as: ESLD, end stage liver disease, end stage liver disease (decompensated liver disease), end-stage liver disease
134 clinical trials for this condition and its sub-types, 125 tagged with Chronic liver failure itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Stem cells for failing livers: does the delivery route matter?
Disease control OngoingResearchers are testing whether human umbilical cord mesenchymal stem cells can help people with end-stage liver disease, and whether the route of delivery changes the outcome. Participants receive the cells either through a peripheral vein or through the hepatic artery. The tria…
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Engineered immune cells aim to calm liver scarring in first human trial
Disease control OngoingThis study tests a new treatment called RTX001 for people with severe liver scarring (cirrhosis) that has led to complications. RTX001 uses the patient's own immune cells, modified in a lab to reduce inflammation and scarring. The trial will enroll 30 adults to check if the thera…
Phase 1/2 • Sponsor: Resolution Therapeutics Limited • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New device aims to improve liver transplant outcomes
Disease control OngoingThis study gives continued access to a device that preserves donated livers before transplant. It includes 120 adults on the transplant waiting list. The goal is to collect safety data and check for early signs of liver problems after surgery.
Sponsor: Organ Recovery Systems, Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Texts and tools could help liver transplant patients stay on track
Disease control OngoingThis study tests whether technology and caregiver support can help liver transplant recipients take their medications correctly. Researchers will enroll 360 adults who received a liver transplant within the past 3 months. Participants will use a system called Way to Health, which…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Could a hormone shield bile ducts in transplanted livers?
Disease control By invitation onlyThis trial investigates whether adding secretin—a hormone that helps produce bicarbonate—during machine perfusion of donor livers can restore the protective 'bicarbonate umbrella' in bile ducts. Researchers will treat up to 20 donor livers with secretin while they are kept on a m…
Phase 1/2 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New registry monitors liver transplant device in thousands of patients
Disease control By invitation onlyThis study is a registry that collects information from up to 5,000 people who received a liver transplant after the donated liver was treated with the VitaSmart HOPE system. The device keeps the liver cool and oxygenated before transplant. The goal is to see how well the device …
Sponsor: Bridge to Life Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Liver transplant bleeding study pulled before starting
Disease control CancelledThis study was designed to see if a new concentrated fibrinogen product works better than the standard one for controlling bleeding in liver transplant patients. It planned to enroll adults having a cadaveric liver transplant who were at risk for low fibrinogen levels. However, t…
Phase 4 • Sponsor: Ezeldeen Abuelkasem • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Stem cell injection aims to prevent deadly liver complication
Disease control By invitation onlyThis early-phase trial tests whether injecting special liver-like cells into the abdominal muscle can help prevent or treat Small-for-Size syndrome, a serious complication that can occur after partial liver surgery. The study involves 12 patients and focuses mainly on safety, che…
Early phase 1 • Sponsor: Zhi-Jun Zhu • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Cell injection aims to repair damaged livers in early trial
Disease control By invitation onlyThis early-phase trial tests a single injection of HCL001 cells in 39 people with decompensated cirrhosis, a severe form of liver disease. The study aims to check safety and see if the treatment can improve liver function. Participants receive one of three dose levels, and resear…
Phase 1/2 • Sponsor: Shanghai Huicun Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a simple drug cut dangerous blood pressure swings in liver transplants?
Disease control OngoingThis study tests whether a drug called Angiotensin II can help control blood pressure during liver transplant surgery, reducing the need for other strong blood pressure medicines. It involves 50 adults with severe liver disease who are receiving a liver from a deceased donor. The…
Phase 2/3 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New program aims to protect liver patients from dangerous painkiller side effects during surgery
Disease control OngoingThis study tests a hospital program to avoid giving NSAIDs or metamizole to people with advanced chronic liver disease who need major surgery. These painkillers are risky for them because they can cause kidney damage, fluid buildup, or bleeding. The program will track how often t…
Sponsor: Parc de Salut Mar • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can amino acid shakes help liver patients regain muscle?
Disease control By invitation onlyThis study tests whether taking branched-chain amino acid (BCAA) supplements twice daily for 12 weeks can improve muscle thickness and nutrition in people with decompensated cirrhosis and ascites (fluid in the belly). Thirty adults with low albumin levels will receive the supplem…
Phase 3 • Sponsor: Mahidol University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Liver transplant patients may dodge kidney failure with simple drug infusion
Prevention OngoingThis study tests whether giving a drug called angiotensin 2 during liver transplant surgery can prevent acute kidney injury, a common and serious complication. About 30 adults with end-stage liver disease will be randomly assigned to receive either the drug plus standard care or …
Phase 4 • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Jun 27, 2026 13:08 UTC
-
Can a sedative shield livers from transplant damage?
Prevention OngoingThis study tests whether the drug dexmedetomidine, given during liver transplant surgery, can protect the new liver and other organs from injury. Sixty adults receiving a living-donor liver transplant will be randomly assigned to receive either the drug or a placebo. The goal is …
Phase 4 • Sponsor: Assiut University • Aim: Prevention
Last updated Jun 27, 2026 07:52 UTC
-
Can a smartwatch and nutrition coaching ease cirrhosis symptoms?
Symptom relief OngoingThis study tests a home monitoring program called LiverWatch for people with advanced liver disease (cirrhosis). Participants get a Fitbit, personalized nutrition advice, and weekly check-ins to boost activity and manage symptoms. The goal is to see if this approach improves qual…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Why are some patients left off the liver transplant list? mayo clinic launches investigation
Knowledge-focused OngoingThis study from Mayo Clinic aims to understand the individual and social reasons why some patients with end-stage liver disease are not listed for or do not receive a liver transplant. Researchers will track 100 patients to see who gets on the waiting list, who receives a transpl…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
Can immune cells predict herpesvirus danger in transplant patients?
Knowledge-focused OngoingThis study looks at how the immune system's T cells respond to two common herpesviruses—cytomegalovirus (CMV) and varicella-zoster virus (VZV)—in people who have had a liver transplant. Because transplant recipients take drugs that suppress their immune system to prevent organ re…
Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Liver transplant study tests best way to manage fluids during surgery
Knowledge-focused OngoingThis pilot study compares two approaches to giving fluids during liver transplant surgery: a restrictive strategy that removes some blood early and returns it later, versus a liberal strategy that keeps blood flow high. The goal is to see if a larger study is possible by checking…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can the liver heal itself? new study tracks unexpected recovery in cirrhosis patients
Knowledge-focused OngoingThis study looks at 300 patients with advanced liver scarring (cirrhosis) caused by hepatitis B or alcohol who have shown signs of getting better. Researchers want to understand what predicts this improvement and how long it lasts. The goal is to create clearer guidelines for whe…
Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists track rare liver diseases in kids to unlock clues
Knowledge-focused PausedThis study follows up to 90 children and young adults with mitochondrial liver diseases to learn how these conditions progress over time. Researchers will collect medical data and samples to better understand the diseases and find markers that predict outcomes. The goal is to imp…
Sponsor: Arbor Research Collaborative for Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Cheaper brain monitoring method tested in liver transplants
Knowledge-focused OngoingThis study compares two non-invasive methods for monitoring brain blood flow during liver transplant surgery: carotid Doppler ultrasound and near-infrared spectroscopy (NIRS). The goal is to see if the simpler, cheaper ultrasound can replace the more expensive NIRS. The study inv…
Sponsor: Inonu University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Can a short video help cancer patients get better palliative care?
Knowledge-focused OngoingThis study tests whether an educational video can help adults with serious cancer understand and use palliative care. 172 participants will either receive standard care plus brochures, or standard care plus a tailored video and extra materials. Researchers will track knowledge, a…
Sponsor: Tulane University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC